These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2887153)
1. Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty. Robin AL; Pollack IP; House B; Enger C Arch Ophthalmol; 1987 May; 105(5):646-50. PubMed ID: 2887153 [TBL] [Abstract][Full Text] [Related]
2. ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery. Brown RH; Stewart RH; Lynch MG; Crandall AS; Mandell AI; Wilensky JT; Schwartz AL; Gaasterland DE; DeFaller JM; Higginbotham EJ Ophthalmology; 1988 Mar; 95(3):378-84. PubMed ID: 3050686 [TBL] [Abstract][Full Text] [Related]
3. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy. Robin AL; Pollack IP; deFaller JM Arch Ophthalmol; 1987 Sep; 105(9):1208-11. PubMed ID: 3307717 [TBL] [Abstract][Full Text] [Related]
4. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise. Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy and tolerability of apraclonidine (ALO 2145, 1%) in the prevention of early ocular hypertonia, after trabeculoretraction using argon laser and posterior capsulotomy using Nd:YAG laser]. Raspiller A; Berrod JP J Fr Ophtalmol; 1992; 15(12):651-6. PubMed ID: 1363731 [TBL] [Abstract][Full Text] [Related]
6. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures. Chevrier RL; Assalian A; Duperré J; Lesk MR Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253 [TBL] [Abstract][Full Text] [Related]
7. Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy. Robin AL Ophthalmology; 1993 May; 100(5):628-33. PubMed ID: 8098520 [TBL] [Abstract][Full Text] [Related]
8. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%. Barnes SD; Campagna JA; Dirks MS; Doe EA Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604 [TBL] [Abstract][Full Text] [Related]
9. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty. Robin AL Ophthalmic Surg; 1991 Jan; 22(1):31-7. PubMed ID: 2014108 [TBL] [Abstract][Full Text] [Related]
10. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. Unal M; Yücel I; Akar Y J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262 [TBL] [Abstract][Full Text] [Related]
11. Prevention of the immediate intraocular pressure rise following argon laser trabeculoplasty. Metcalfe TW; Etchells DE Br J Ophthalmol; 1989 Aug; 73(8):612-6. PubMed ID: 2669939 [TBL] [Abstract][Full Text] [Related]
12. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Kitazawa Y; Taniguchi T; Sugiyama K Ophthalmic Surg; 1989 Jan; 20(1):49-52. PubMed ID: 2648232 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery. Sciscio A; Casswell AG Br J Ophthalmol; 2001 Feb; 85(2):164-8. PubMed ID: 11159479 [TBL] [Abstract][Full Text] [Related]
14. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty. David R; Spaeth GL; Clevenger CE; Perell HF; Siegel LI; Henry JC; Stiles MC; Passo MS; Stamper RL; Walt JG Arch Ophthalmol; 1993 Oct; 111(10):1387-90. PubMed ID: 8105773 [TBL] [Abstract][Full Text] [Related]
15. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Pollack IP; Brown RH; Crandall AS; Robin AL; Stewart RH; White GL Arch Ophthalmol; 1988 Jun; 106(6):754-7. PubMed ID: 3369999 [TBL] [Abstract][Full Text] [Related]
17. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes. Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127 [TBL] [Abstract][Full Text] [Related]
18. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. Chen TC J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772 [TBL] [Abstract][Full Text] [Related]
19. Effect of apraclonidine hydrochloride on acute introacular pressure rise after argon laser iridotomy. Hong C; Song KY; Park WH; Sohn YH Korean J Ophthalmol; 1991 Jun; 5(1):37-41. PubMed ID: 1682521 [TBL] [Abstract][Full Text] [Related]
20. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]